The 1 analysts offering 12-month price forecasts for Evofem Biosciences Inc have a median target of 225.00, with a high estimate of 225.00 and a low estimate of 225.00. The median estimate represents a +132,252.94% increase from the last price of 0.17.
The current consensus among 1 polled investment analysts is to Buy stock in Evofem Biosciences Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$7.50
Reporting Date Nov 14
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.